Public Company News

PharmAbcine announces a research collaboration with LegoChem Biosciences

DAEJEON, South Korea, Jan. 11, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of fully human antibody therapeutics, announced today that the company has entered into a research collaboration agreement with LegoChem Bioscience...

2021-01-11 21:00 1643

Luokung Announces EMG Awarded Exclusive 2020 Golden Globe Award for its "HD Map" Functionality

BEIJING, Jan. 11, 2021 /PRNewswire/ -- Luokung Technology Corp. (NASDAQ: LKCO) ("Luokung" or the "Company"), a leading interactive location-based services and big data processing technology company inChina, today announced that the Company's previously announced acquisition candidate, eMapgo Tech...

2021-01-11 21:00 5697

Happiness Biotech's E-Commerce Business - Happy Buy, Achieved Over 70% Growth in December

NANPING, China, Jan. 11, 2021 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, announced today that Happy Buy, the Company's wholly-owned subsidiary focusing on e-commerce business, has achiev...

2021-01-11 21:00 7182

Lion Announces New Appointment to Board of Directors

HONG KONG, Jan. 11, 2021 /PRNewswire/ -- Lion Group Holding Ltd. ("Lion" or "the Company") (NASDAQ: LGHL), operator of an all-in-one trading platform that offers a wide spectrum of products and services with a focus on Chinese investors, today announced Mr. Guandong (Gordon) Wang has been appoint...

2021-01-11 20:00 5779

Acer Reports Consolidated Revenues for Q4'20 at NT$82.60 Billion, Highest Quarter in Six Years; and for December at NT$28.36 Billion

TAIPEI, Jan. 11, 2021 /PRNewswire/ -- Acer Inc. (TWSE: 2353) announced today its consolidated revenues forDecember 2020 at NT$28.36 billion, up 21.5% year-on-year (YoY). Significant consolidated revenue growths were shown in Q4'20 withNT$82.60 billion, up 34.1% YoY and 3.2% quarter-on-quarter, ma...

2021-01-11 18:51 8504

FinVolution Group Announces Continued Purchase of Shares by Chairman

SHANGHAI, Jan. 11, 2021 /PRNewswire/ -- FinVolution Group ("FinVolution", or the "Company") (NYSE: FINV), a leading fintech platform inChina, today announced that Mr.Shaofeng Gu, Chairman and Chief Innovation Officer of the Company, has informed the Company that he purchased in his personal capac...

2021-01-11 17:00 8865

Johnson Matthey and SFC Energy AG sign multi-million pound deal and joint development agreement for the supply of more sustainable fuel cell components

- Johnson Matthey and SFC Energy AG sign new multi-million pound three year agreement for the supply of Membrane Electrode Assemblies (MEAs). - JM will supply at least 400,000 Membrane Electrode Assemblies. - Joint development of next generation MEA through a more efficient process and reduction...

2021-01-11 16:30 3768

Baidu Announces Plan to Establish an Intelligent EV Company and Forms Strategic Partnership with Geely

BEIJING, Jan. 10, 2021 /PRNewswire/ -- Baidu, Inc. (NASDAQ: BIDU) ("Baidu" or the "Company"), a leading Internet platform and AI company, today announced its plan to establish a company to produce intelligent electric vehicles (EV), and that it has entered into a strategic partnership with multin...

2021-01-11 10:00 13168

Cognizant to Acquire Servian, a Leading Australian Data and Analytics Consulting Firm

Acquisition Will Enhance Cognizant's Digital Portfolio and Market Presence in Australia and New Zealand SYDNEY, Jan. 11, 2021 /PRNewswire/ -- Cognizant (Nasdaq: CTSH) today announced it has entered into an agreement to acquireServian, a Sydney, Australia-based, privately-held enterprise transfor...

2021-01-11 05:30 11425

VISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development and Commercialization of its Innovative Endocrinology Therapies in Greater China

SHANGHAI, Jan. 9, 2021 /PRNewswire/ -- VISEN Pharmaceuticals, a biotech company focused on developing and commercializing innovative endocrine drugs that address significant unmet needs for patients inGreater China, announced today the closing of a$150 million Series B financing. The round...

2021-01-09 11:06 5933

Appian Selected by Accenture as a Core Partner in the INTIENT Network for Life Sciences

Appian brings low-code speed and automation power to help drive innovation in drug discovery and scientific research MCLEAN, Va., Jan. 9, 2021 /PRNewswire/ -- Appian (NASDAQ: APPN) today announced that it has joined Accenture's INTIENT partner ecosystem as a core partner. The ecosystem is design...

2021-01-09 08:55 10508

Pingtan Marine Enterprise Ltd. Closes $4.0 Million Registered Direct Offering

FUZHOU, China, Jan. 8, 2021 /PRNewswire/ -- Pingtan Marine Enterprise Ltd. (Nasdaq: PME), ("Pingtan," or the "Company"), a fishing company based in the People's Republic of China, announced today that it has sold $4.0 million of the Company's Series A Convertible Preferred Shares, par value$0.001...

2021-01-09 05:52 7161

Poema Global Holdings Corp. Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriter's Option to Purchase Additional Units

BERLIN and HONG KONG, Jan. 8, 2021 /PRNewswire/ -- Poema Global Holdings Corp. (the "Company" or "Poema Global"), a special purpose acquisition company affiliated with Princeville Capital formed for the purpose of entering into a combination with one or more businesses, today announced the closin...

2021-01-09 05:30 13307

South Korea's Hancom Group to Participate at the All Digital CES 2021

SAN JOSE, Calif., Jan. 8, 2021 /PRNewswire/ -- Hancom Group, a leader in creating game-changing technology ecosystems has announced that it will participate in the All Digital CES 2021 held from Jan. 11 to 14.   The company will present its visions for making the world Smarter, ...

2021-01-09 01:00 5303

SOS Ltd. Announces Pricing of Approximately $25.0 Million Registered Direct Offering

QINGDAO, China, Jan. 8, 2021 /PRNewswire/ -- SOS Limited (NYSE: SOS) (the "Company" or "SOS"), a high-tech company providing a wide range of data mining and marketing analysis services to its corporate and individual members inChina , announced today that it has entered into a securities purchase ...

2021-01-08 22:15 12099

Hollysys Announces Management's Plan to Purchase Public Market Shares

BEIJING, Jan. 8, 2021 /PRNewswire/ -- Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) ("Hollysys" or the "Company") today announces that it has been notified that certain members of the Company's management team plan to purchase the Company's ordinary shares from the public market at market ...

2021-01-08 19:10 10510

Hollysys' Board of Directors Rejects Unsolicited Offer

BEIJING, Jan. 8, 2021 /PRNewswire/ -- Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) ("Hollysys" or the "Company"), today announced that its Board of Directors (the "Board"), after careful review and consideration and with the assistance of its executive management team as well as outside f...

2021-01-08 19:00 11908

ReneSola Power Announces Sale of 12.3 MW of Projects in Hungary

STAMFORD, Conn., Jan. 8, 2021 /PRNewswire/ -- ReneSola Ltd ("ReneSola Power" or the "Company") (www.renesolapower.com ) (NYSE: SOL), a leading fully integrated solar project developer, today announced that it entered into an agreement to sell a portfolio of projects...

2021-01-08 19:00 4964

ChipMOS REPORTS 20.1% YoY INCREASE IN DECEMBER 2020 REVENUE; 13.3% YoY INCREASE IN 4Q20 REVENUE; 13.1% YoY INCREASE IN FY20 REVENUE

HSINCHU, Jan. 8, 2021 /PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange: 8150 and NASDAQ: IMOS), an industry leading provider of outsourced semiconductor assembly and test services ("OSAT"),...

2021-01-08 19:00 12084

Gracell Biotechnologies Announces Pricing of Initial Public Offering

SUZHOU and SHANGHAI, China, Jan. 8, 2021 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ:GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to discovering and developing breakthrough cell therapies to address major industry challenges and fulfill unmet medical ne...

2021-01-08 14:55 9969